Skip to main content
Clinical Trials/CTIS2024-510701-29-00
CTIS2024-510701-29-00
Recruiting
Phase 1

Randomized Clinical Trial of the use of Propofol as a sedative agent versus spinal analgesia with bupivacaine in External Cephalic Version (PropoSpinECV) - IMIB-ECV-2024-01

Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia0 sites270 target enrollmentMarch 1, 2024

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
External Cephalic Version
Sponsor
Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
Enrollment
270
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 1, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional clinical trial of medicinal product

Investigators

Sponsor
Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia

Eligibility Criteria

Inclusion Criteria

  • Voluntary participation., Older than 18 years, Non\-cephalic presentation., Desire to attempt a vaginal birth., Normal blood count and coagulation prior to the intervention

Exclusion Criteria

  • Age under 18 years old., Thrombocytopenia (\<85,000 platelets)., Maternal spinal anomaly., Intolerance or allergy to Propofol or any of its components., Intolerance or allergy to bupivacaine or any of its components., Contraindication for intrathecal sedation or analgesia, Multiple gestation., Cephalic presentation., Risk of fetal compromise., Unexplained active bleeding., Absolute contraindication for vaginal delivery (Placenta Previa), 2 or more previous cesarean sections., Previous myomectomy with entry into the uterine cavity., Maternal fever.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Comparison blood glucose change in intravenous anesthesia with Propofol and inhalation anesthesia with Isofluran in child between 4-6 years old that candidate for dental procedure in general anesthesia.blood glucose change.Hypoglycemia (spontaneous) - drug- induced
IRCT201109034224N17Vice Chancellery for Research of Dental College- Islamic Azad University of Khorasgan26
Active, not recruiting
Not Applicable
A randomized study to evaluate whether there is a difference in survival between two different forms of anaesthesia. The study will evaluate patients that are scheduled for a surgery for either breast-, colon- or rectalcancer.Patients with breast- or colorectal cancer that will undergo radical surgery for this cancer. During the surgery general aneasthesia with either propofol or sevoflurane will be used.MedDRA version: 14.1Level: PTClassification code 10038038Term: Rectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10009944Term: Colon cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10006187Term: Breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
EUCTR2013-002380-25-SECKF at Västmanlands hospital Västerås
Active, not recruiting
Phase 1
A randomized study to evaluate whether there is a difference in survival between two different forms of anaesthesia. The study will evaluate patients that are scheduled for a surgery for either breast-, colon- or rectalcancer.Patients with breast- or colorectal cancer that will undergo radical surgery for this cancer. During the surgery general aneasthesia with either propofol or sevoflurane will be used.MedDRA version: 20.0Level: PTClassification code 10038038Term: Rectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10009944Term: Colon cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10006187Term: Breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
EUCTR2013-002380-25-HRCKF at Västmanlands hospital Västerås8,000
Completed
Not Applicable
A randomized parallel-group trial of propofol versus midazolam for sadation during ERCP
JPRN-UMIN000007732Hiroshima University hospital100
Completed
Phase 3
A Randomized, Single-blind, Propofol-controlled Phase III Study Evaluating the Efficacy and Safety of Remimazolam in General Anesthesia in Adult Patients Undergoing Cardiac Surgery, including Follow-up Sedation in the Post-anesthesia Care Unit / Intensive Care UnitnarcoseAnesthesianarcosis10082206
NL-OMON42664PAION UK Limited27